Target intelligence / Profile preview

Osteoclast stimulating factor 1 (OSTF1)

Target
OSTF1
Molecular classification
Intracellular signaling protein, SH3-domain containing protein, Ankyrin repeat protein
01

Overview

Osteoclast stimulating factor 1 is a protein produced by the OSTF1 gene, located on chromosome 9. It promotes bone resorption and influences osteoclast formation through intracellular signaling, cytoskeletal reorganization, and protein-protein interactions. OSTF1 contains an SH3 domain and ankyrin repeats, and it is found in the cytosol, nucleus, and Golgi apparatus. OSTF1 interacts with several proteins, including c-Src, Cbl, myosin 1E, and SMN1/2, influencing bone development, cell motility, chromatin remodeling, and RNA splicing. Mutations or deletions of OSTF1 are associated with a spectrum of bone and retinal diseases, as well as developmental syndromes. There are currently no approved drugs that specifically target OSTF1. Interventions affecting OSTF1 could have substantial effects on bone density and developmental outcomes.

Other names
OSFSH3P2bA235O14.1
02

Mechanism of action

Not applicable; no drugs explicitly target OSTF1 per current literature. Its role is intracellular modulation of bone resorption and signaling rather than being a drug target itself

03

Biological functions

Regulation of osteoclast formationBone resorptionCytoskeletal reorganizationRNA splicingChromatin remodelingProtein-protein interactionsNegative regulation of cell motility
04

Disease associations

Bone remodeling disorders (e.g., Gorham-Stout disease, melorheostosis, osteomesopyknosis, hyperostosis corticalis generalisata)Retinal and developmental syndromes (e.g., X-linked retinal dysplasia, retinitis pigmentosa, severe childhood-onset retinal dystrophy)Microdeletion syndromes associated with skeletal and developmental abnormalities
05

Safety considerations

Not documented for OSTF1 as a therapeutic target; manipulation may affect bone structure, motility, and diverse signaling pathways, posing theoretical risks of altered bone density and developmental effects

Beyond the preview

Go deeper on Osteoclast stimulating factor 1 (OSTF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteoclast stimulating factor 1 (OSTF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call